Pharmacological evidence for taurine as an inhibitory neurotransmitter in the cerebellum.
Sakai
Y
Y
Okamoto
K
K
Kimura
H
H
D000818:Animals; D001581:Benzothiadiazines / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002531:Cerebellum / Q000187:drug effects / Q000502:physiology*; D002712:Chlorides / Q000378:metabolism; D003712:Dendrites / Q000187:drug effects / Q000502:physiology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000494:pharmacology / Q000502:physiology*; D011689:Purkinje Cells / Q000187:drug effects / Q000502:physiology; D013654:Taurine / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*
D001581:Benzothiadiazines; D002712:Chlorides; D018377:Neurotransmitter Agents; D013654:Taurine; C032946:6-aminomethyl-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide; D002118:Calcium